Shuttle Pharmaceuticals Statistics
Share Statistics
Shuttle Pharmaceuticals has 6.26M
shares outstanding. The number of shares has increased by -62.74%
in one year.
| Shares Outstanding | 6.26M |
| Shares Change (YoY) | -62.74% |
| Shares Change (QoQ) | 70.75% |
| Owned by Institutions (%) | 0.52% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 7,603 |
| FTD / Avg. Volume | 1.01% |
Short Selling Information
The latest short interest is 136.08K, so 2.17% of the outstanding
shares have been sold short.
| Short Interest | 136.08K |
| Short % of Shares Out | 2.17% |
| Short % of Float | 2.51% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
| PE Ratio | 0 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | 0 |
| P/FCF Ratio | -0.34 |
| PEG Ratio | 0 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Shuttle Pharmaceuticals.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.44,
with a Debt / Equity ratio of 2.33.
| Current Ratio | 1.44 |
| Quick Ratio | 1.44 |
| Debt / Equity | 2.33 |
| Debt / EBITDA | -0.21 |
| Debt / FCF | -225.4 |
| Interest Coverage | 885.43 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-1,016,088,555.56 |
| Employee Count | 9 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -93.11% in the
last 52 weeks. The beta is 0.59, so Shuttle Pharmaceuticals's
price volatility has been higher than the market average.
| Beta | 0.59 |
| 52-Week Price Change | -93.11% |
| 50-Day Moving Average | 0.37 |
| 200-Day Moving Average | 1.09 |
| Relative Strength Index (RSI) | 32.25 |
| Average Volume (20 Days) | 752,427 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -7.7B |
| Net Income | -9.14B |
| EBITDA | -7.7B |
| EBIT | -9.15B |
| Earnings Per Share (EPS) | -3186.21 |
Full Income StatementBalance Sheet
The company has 1.92B in cash and 1.65B in
debt, giving a net cash position of 268.55M.
| Cash & Cash Equivalents | 1.92B |
| Total Debt | 1.65B |
| Net Cash | 268.55M |
| Retained Earnings | -34.58B |
| Total Assets | 2.51M |
| Working Capital | 677.15K |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -7.33M
and capital expenditures 0, giving a free cash flow of -7.33M.
| Operating Cash Flow | -7.33M |
| Capital Expenditures | n/a |
| Free Cash Flow | -7.33M |
| FCF Per Share | -2.55 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
